MedAmicus to sell Schick densitometer
Medical technology firm MedAmicus has signed an agreement with Schick Technologies to distribute that firm's accuDEXA bone densitometer (SCAN 4/15/98). MedAmicus, of Plymouth, MN, will add accuDEXA to its line of diagnostic testing products it
Medical technology firm MedAmicus has signed an agreement with Schick Technologies to distribute that firm's accuDEXA bone densitometer (SCAN 4/15/98). MedAmicus, of Plymouth, MN, will add accuDEXA to its line of diagnostic testing products it sells to physicians' offices. The company will price the densitometer at under $13,000, with shipments expected to begin by the end of April.
In other Schick news, the Long Island City, NY, company reported on April 14 that it expects revenues for its fourth quarter (end-March) to be between $12 million and $13 million. The figures are much higher than the $5.4 million in sales Schick recorded in the same period last year, but are short of expectations due to the late delivery of components from a supplier, which prevented Schick from fulfilling orders worth between $2 million and $3 million. The delays have been resolved, and the products should ship in its first fiscal quarter, according to Schick.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
